(1 - 10 from 10
)
Evonik's Dr. Klaus Stingl on the Growth of Highly Potent APIswww.chemanager-online.com › news › evoniks-dr-klaus-stingl-growth-hig...
www.chemanager-online.com
Dr. Klaus Stingl, Manager Exclusive Synthesis Health Care business line, Evonik. Pacesetter - Evonik recently made news when it opened its ...
Evonik’s Dr. Klaus Stingl on the Growth of Highly...
www.chemanager-online.com
Evonik’s Dr. Klaus Stingl on the Growth of Highly Potent APIs. Pacesetter - Evonik recently made news when it opened its laboratory for highly potent APIs (HPAPIs
Evonik etabliert neues Geschäftsgebiet Health Care
corporate.evonik.de
... in die Produktlinie Exklusivsynthese unter der Leitung von Dr. Klaus Stingl und in die Produktlinie Rexim® unter der Leitung von Dr. Thomas ...
sorted by relevance / date